BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33368448)

  • 21. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
    Al-Aly Z; Maddukuri G; Xie Y
    Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4.
    Giusti S; Lin Y; Sogbetun F; Nakhoul N; Liu S; Shi L; Batuman V
    Am J Med Sci; 2021 Nov; 362(5):453-461. PubMed ID: 34033809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
    Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
    Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-Dependent Effects of Acute Kidney Injury on End-Stage Kidney Disease and Mortality in Patients with Moderate to Severe Chronic Kidney Disease.
    Chou YH; Lai TS; Lin YC; Chiang WC; Chu TS; Lin SL; Chen YM
    Nephron; 2023; 147(6):329-336. PubMed ID: 36649699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of oral antithrombotic use in patients with chronic kidney disease.
    Laville SM; Lambert O; Hamroun A; Metzger M; Jacquelinet C; Laville M; Frimat L; Fouque D; Combe C; Ayav C; Pecoits-Filho R; Stengel B; Massy ZA; Liabeuf S;
    Clin Transl Sci; 2021 Nov; 14(6):2242-2253. PubMed ID: 34080321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study.
    Ishikura K; Uemura O; Hamasaki Y; Ito S; Wada N; Hattori M; Ohashi Y; Tanaka R; Nakanishi K; Kaneko T; Honda M; ;
    Nephrol Dial Transplant; 2014 Apr; 29(4):878-84. PubMed ID: 24516225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction.
    Mody P; Wang T; McNamara R; Das S; Li S; Chiswell K; Tsai T; Kumbhani D; Wiviott S; Goyal A; Roe M; de Lemos JA
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):43-50. PubMed ID: 29293980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of anti-ulcer agents and the risk of chronic kidney disease: a meta-analysis.
    Sun J; Sun H; Cui M; Sun Z; Li W; Wei J; Zhou S
    Int Urol Nephrol; 2018 Oct; 50(10):1835-1843. PubMed ID: 29948864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.
    Laville SM; Metzger M; Stengel B; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Ayav C; Speyer E; Robinson BM; Massy ZA; Liabeuf S;
    Br J Clin Pharmacol; 2018 Dec; 84(12):2811-2823. PubMed ID: 30110711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
    Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
    Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care.
    Garofalo C; Provenzano M; Andreucci M; Pisani A; De Nicola L; Conte G; Borrelli S
    Nephrol Dial Transplant; 2021 Dec; 36(12):2232-2240. PubMed ID: 33877358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.
    Yamamoto R; Shinzawa M; Isaka Y; Yamakoshi E; Imai E; Ohashi Y; Hishida A;
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1825-1832. PubMed ID: 30442866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.